Advanced mesothelioma or other solid tumors harboring certain molecular alterations in the Hippo pathway
Conditions
Interventions
None listed
Sponsors
Novartis Pharma AG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Countries
France, Germany, Italy, Netherlands, Spain
Outcome results
None listed